by akronbiotech

Riding the commercial approvals of two CAR T immunotherapies last year, the energized regenerative medicine community will be coming together in Montreal for the Annual ISCT Global Meeting and Exhibition from Wednesday May 2nd through Saturday May 5th.

Don’t miss Dr. Claudia Zylberberg, CEO of Akron Biotech, during the Quality & Operations Track speaking about ‘Filling Information Gaps to Accelerate Commercialization: Two Case Studies in the Development of ISO Standards for Regenerative Medicine’ on Thursday, May 3rd at 11am in Room 520BE. The session, entitled ‘Progress in the World of Standards for Cell and Gene Therapies’, is chaired by Sowmya Viswanathan (University of Toronto), and also features Jiwen Zhang (Standards Coordinating Body), Jonathan Campbell (LGC) and Yutaka Yanagita (Astellas).

Kim Bure, Senior Director for Global Sales, and Shikira Gray, Senior Director for North America, will be available at Exhibition Booth 700 throughout the conference to further explain Akron’s focus on providing the highest quality of cGMP cytokines and growth factors in the market and introducing DMSO-free options into your cryoprotective strategies.

Travel safe – looking forward to seeing you and enjoying some poutine!

Related Post

Leave A Comment